Jeffrey Stein - Mar 27, 2023 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Signature
/s/ Shane Ward, Attorney-in-Fact
Stock symbol
CDTX
Transactions as of
Mar 27, 2023
Transactions value $
$0
Form type
4
Date filed
3/29/2023, 05:30 PM
Previous filing
Feb 23, 2023
Next filing
Jun 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Award $0 +272K +29.2% $0.00 1.2M Mar 27, 2023 Direct F1, F2
holding CDTX Common Stock 282K Mar 27, 2023 By trust
holding CDTX Common Stock 42K Mar 27, 2023 By son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDTX Employee Stock Option (right to buy) Award $0 +544K $0.00 544K Mar 27, 2023 Common Stock 544K $1.01 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents time-based Restricted Stock Units (RSUs) granted on March 27, 2023. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2024, 2025, and 2026, subject to continuous service through each such vesting date.
F2 Includes 8,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) on May 20, 2022 and November 18, 2022.
F3 The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 27, 2023.